HEALTH● LOWJul 8 · Jul 8, 2026, 1:31 PM
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
CNBC
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH20m agoLagos begins mandatory health insurance enforcement January 2027Vanguard NigeriaHEALTH56m agoBreast cancer prevention starts with knowing your riskThe HillHEALTH58m agoMedical experts warn climate change is now a 'global health emergency'RFI [en]HEALTH1h agoCurrent, former CMS leaders offer advice on Medicare changes aheadThe Hill